Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
暂无分享,去创建一个
[1] G. Murphy,et al. Purification of a human prostate specific antigen. , 1979, Investigative urology.
[2] L. Sullivan,et al. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate. , 1981, The Journal of urology.
[3] H. Lilja. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. , 1985, The Journal of clinical investigation.
[4] G. Murphy,et al. Use of human prostate-specific antigen in monitoring prostate cancer. , 1981, Cancer research.
[5] G. Murphy,et al. Prostate antigen: a marker for human prostate epithelial cells. , 1981, Journal of the National Cancer Institute.
[6] R. Schifman,et al. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. , 1989, American journal of clinical pathology.
[7] C. Lazure,et al. Dog prostate arginine esterase is related to human prostate specific antigen. , 1986, Clinical and investigative medicine. Medecine clinique et experimentale.
[8] J. Oesterling,et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.
[9] H. Lilja,et al. Molecular cloning of human prostate specific antigen cDNA , 1987, FEBS letters.
[10] J. Heremans,et al. Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.
[11] A. Bruce,et al. Tumor Markers in Prostatic Disease , 1987 .
[12] T. M. Chu,et al. The proteolytic activity of human prostate-specific antigen. , 1984, Biochemical and biophysical research communications.
[13] G. Murphy,et al. What's new in tumor markers for prostate cancer? , 1986, Urology.
[14] Takanori Nakamura,et al. The chymotrypsin‐like activity of human prostate‐specific antigen, γ‐seminoprotein , 1987 .
[15] T. Stamey,et al. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. , 1988, American journal of clinical pathology.
[16] P. Riegman,et al. Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. , 1989, Biochemical and biophysical research communications.
[17] H. Lilja,et al. The predominant protein in human seminal coagulate. , 1985, Scandinavian journal of clinical and laboratory investigation.
[18] J. Epstein,et al. Blood Group Antigen Expression in Dysplasia: and Adenocarcinoma of the Prostate , 1990, The American journal of surgical pathology.
[19] G. Murphy,et al. A prostate antigen in sera of prostatic cancer patients. , 1980, Cancer research.
[20] N. Yang,et al. Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. , 1985, Cancer research.
[21] G. Sensabaugh,et al. Postcoital detection of a male-specific semen protein. Application to the investigation of rape. , 1985, The New England journal of medicine.
[22] D R Turner,et al. Reappraisal of the causes of the "hook effect" in two-site immunoradiometric assays. , 1982, Analytical biochemistry.
[23] J. Oesterling,et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.
[24] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.
[25] D. Newling,et al. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. , 1988, British journal of urology.
[26] K. Fokas,et al. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. , 1988, The Journal of urology.
[27] J. Epstein,et al. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications. , 1984, Human pathology.
[28] R. Vihko,et al. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma. , 1981, Cancer research.
[29] S. Vernon,et al. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry. , 1983, The Journal of urology.
[30] I. Leav,et al. Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. , 1988, American journal of clinical pathology.
[31] R. Schifman,et al. Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. , 1987, Clinical chemistry.
[32] R. H. Anholt,et al. Demonstration of the prostatic origin of metastases. An immunohistochemical method for formalin‐fixed embedded tissue , 1978, Cancer.
[33] K. Watt,et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Oesterling,et al. Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. , 1987, Clinical chemistry.
[35] S. Kagawa,et al. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen. , 1984, Urologia internationalis.
[36] M. Nadji,et al. Prostatic origin of tumors. An immunohistochemical study. , 1980, American journal of clinical pathology.
[37] T. Stamey,et al. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. , 1989, The Journal of urology.
[38] P. Smith,et al. Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. , 1987, British journal of urology.
[39] B. Churchill,et al. A comparative study of intravenous urograms and radionuclide renal scans in diagnosis of renal trauma. , 1987, Urology.
[40] B. Trump,et al. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen. , 1984, Cancer research.
[41] J. Oesterling,et al. Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status? , 1991, The Journal of urology.
[42] H. Zincke,et al. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation) , 1991, The Journal of urology.
[43] B. Morris,et al. Primary structure of a human glandular kallikrein gene. , 1987, DNA.
[44] T. Maatman. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate. , 1989, The Journal of urology.
[45] D. Bostwick,et al. Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.
[46] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. , 1989, The Journal of urology.
[47] J. Oesterling,et al. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. , 1987, Clinical chemistry.
[48] R. Vessella,et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. , 1989, The Journal of urology.
[49] D. Bostwick,et al. Prostatic intraepithelial neoplasia (PIN). , 1989, Urology.
[50] S. Torp-Pedersen,et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. , 1989, Radiology.
[51] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. , 1989, The Journal of urology.
[52] Sutherland,et al. Characterization of a monoclonal antibody to a conserved epitope on human seminal vesicle-specific peptides: a novel probe/marker system for semen identification. , 1986, Biology of reproduction.
[53] L. Shaw,et al. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. , 1986, Urology.
[54] B. Wolf,et al. Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the "hook effect". , 1988, Clinical chemistry.
[55] F. Freiha,et al. Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates , 1989, Cancer.
[56] P. Lundberg,et al. Determination of prostate-specific antigen in serum by immunoradiometric assay. , 1990, Clinical chemistry.
[57] G. Sensabaugh,et al. Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification. , 1978, Journal of forensic sciences.
[58] R. Schifman,et al. The effect of digital rectal examination on serum levels of prostatic-specific antigen. , 1988, Archives of Pathology & Laboratory Medicine.
[59] P. Riegman,et al. Molecular cloning and characterization of novel prostate antigen cDNA's. , 1988, Biochemical and biophysical research communications.
[60] W. Cooner,et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.
[61] G. Murphy,et al. A simplified purification procedure for human prostate antigen. , 1982, Oncology.
[62] G. Croghan,et al. Prostate-specific antigenic domain of human prostate specific antigen identified with monoclonal antibodies. , 1989, The Journal of urology.
[63] J. Herr,et al. Immunohistochemical localization of the MHS‐5 antigen in principal cells of human seminal vesicle epithelium , 1986, The Anatomical record.
[64] J. Lynch,et al. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. , 1988, Urology.
[65] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. , 1989, The Journal of urology.
[66] C. Boring,et al. Cancer statistics, 1990 , 1990, CA: a cancer journal for clinicians.
[67] G. Murphy,et al. Prostatic‐specific antigen: An immunohistologic marker for prostatic neoplasms , 1981, Cancer.
[68] W. Catalona,et al. Differences in values obtained with 2 assays of prostate specific antigen. , 1988, The Journal of urology.
[69] T. Stamey,et al. Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard. , 1990, The Journal of urology.
[70] G. Murphy,et al. Prostate antigen: A new potential marker for prostatic cancer , 1981, The Prostate.
[71] A. Rademaker,et al. Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.
[72] W. Catalona,et al. Clinical use of prostate specific antigen in patients with prostate cancer. , 1989, The Journal of urology.
[73] J. Masters,et al. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice. , 1985, British journal of urology.
[74] A. Foti,et al. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. , 1977, The New England journal of medicine.
[75] J. Oesterling,et al. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. , 1991, The Journal of urology.
[76] H. Svanholm. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.
[77] C. Li,et al. Immunohistochemical diagnosis of prostatic cancer with metastasis , 1980, Cancer.
[78] J. Griffiths. Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease. , 1980, Clinical chemistry.
[79] T. Stamey,et al. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .
[80] A. R. Kendall,et al. Immunoperoxidase localization of prostate‐specific antigen , 1982, The American journal of surgical pathology.
[81] R. Liedtke,et al. Measurement of prostate-specific antigen by radioimmunoassay. , 1984, Clinical chemistry.
[82] R L Vessella,et al. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. , 1987, The Journal of urology.
[83] G. Prout,et al. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. , 1983, The Journal of urology.
[84] J. Oesterling,et al. The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. , 1989, The Journal of urology.
[85] R. S. Mcgee,et al. Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30). , 1988, Biology of reproduction.
[86] P. Lange,et al. Prostate-Specific Antigen: Its Role in Early Detection, Staging, and Monitoring of Prostatic Carcinoma , 1989 .
[87] D. Siders,et al. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. , 1989, Urology.
[88] S. Torp-Pedersen,et al. Prostate Cancer: Comparison of Transrectal US and Digital Rectal Examination for Screening , 1988, Radiology.
[89] T. S. Li,et al. Isolation and characterization of two specific antigens of human seminal plasma. , 1973, Fertility and sterility.
[90] G. Murphy,et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. , 1980, Cancer research.
[91] L. Sobin,et al. Prostatic acid phosphatase activity in carcinoid tumors , 1986, Cancer.